{
    "id": 18486,
    "fullName": "TTK I598F",
    "impact": "missense",
    "proteinEffect": "no effect - predicted",
    "geneVariantDescriptions": [
        {
            "description": "TTK I598F lies within the protein kinase domain of the Ttk protein (UniProt.org). I598F confers resistance to Ttk (Mps1) inhibitors by preventing binding to the Ttk protein, but otherwise has activity similar to wild-type (PMID: 26364596).",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 4449,
                    "pubMedId": 26364596,
                    "title": "Molecular basis underlying resistance to Mps1/TTK inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26364596"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 7272,
        "geneSymbol": "TTK",
        "terms": [
            "TTK",
            "CT96",
            "ESK",
            "MPH1",
            "MPS1",
            "MPS1L1",
            "PYT"
        ]
    },
    "variant": "I598F",
    "createDate": "02/23/2016",
    "updateDate": "10/24/2019",
    "referenceTranscriptCoordinates": {
        "id": 122111,
        "transcript": "NM_003318",
        "gDna": "chr6:g.80035285A>T",
        "cDna": "c.1792A>T",
        "protein": "p.I598F",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 4695,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, cancer cell lines expressing Ttk (Mps1) I598F were resistant to inhibition by Cpd-5 (PMID: 26364596).",
            "molecularProfile": {
                "id": 18828,
                "profileName": "TTK I598F"
            },
            "therapy": {
                "id": 3465,
                "therapyName": "Cpd-5",
                "synonyms": null
            },
            "indication": {
                "id": 162,
                "name": "cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 4449,
                    "pubMedId": 26364596,
                    "title": "Molecular basis underlying resistance to Mps1/TTK inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26364596"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 4704,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, cancer cell lines expressing Ttk (Mps1) I598F were resistant to inhibition by AZ3146 (PMID: 26364596).",
            "molecularProfile": {
                "id": 18828,
                "profileName": "TTK I598F"
            },
            "therapy": {
                "id": 3117,
                "therapyName": "AZ3146",
                "synonyms": null
            },
            "indication": {
                "id": 162,
                "name": "cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 4449,
                    "pubMedId": 26364596,
                    "title": "Molecular basis underlying resistance to Mps1/TTK inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26364596"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 4700,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, cancer cell lines expressing Ttk (Mps1) I598F were resistant to inhibition by NMS-P715 (PMID: 26364596).",
            "molecularProfile": {
                "id": 18828,
                "profileName": "TTK I598F"
            },
            "therapy": {
                "id": 3107,
                "therapyName": "NMS-P715",
                "synonyms": null
            },
            "indication": {
                "id": 162,
                "name": "cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 4449,
                    "pubMedId": 26364596,
                    "title": "Molecular basis underlying resistance to Mps1/TTK inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26364596"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 18828,
            "profileName": "TTK I598F",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 122112,
            "transcript": "XM_011536099",
            "gDna": "chr6:g.80035285A>T",
            "cDna": "c.1792A>T",
            "protein": "p.I598F",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 122111,
            "transcript": "NM_003318",
            "gDna": "chr6:g.80035285A>T",
            "cDna": "c.1792A>T",
            "protein": "p.I598F",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}